Complete Medical Form Answer a few quick health questions to help us understand your symptoms and goals
Patients should be aware that while some side effects may diminish over time, others may require medical attention
Kidney Disease Management: In January 2025, the FDA approved semaglutide to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease
Our doctors are considered some of the areas top-rated plastic surgeons and are renowned for their exceptional skill and expertise in performing plastic surgery procedures, including Lipo 360, in the greater Washington, DC metropolitan area, including Maryland and Northern Virginia
In clinical studies, around 82.8% of semaglutide participants reported gastrointestinal adverse events, with most being mild to moderate and transient in nature
Hans Christian Hagedorn, short-tempered physician